1.2372
price down icon5.00%   -0.0628
 
loading
Schlusskurs vom Vortag:
$1.30
Offen:
$1.3
24-Stunden-Volumen:
192.08K
Relative Volume:
0.46
Marktkapitalisierung:
$59.85M
Einnahmen:
$1.82M
Nettoeinkommen (Verlust:
$-267.63M
KGV:
-0.0614
EPS:
-20.1639
Netto-Cashflow:
$-50.53M
1W Leistung:
-15.99%
1M Leistung:
-25.15%
6M Leistung:
-40.62%
1J Leistung:
-83.06%
1-Tages-Spanne:
Value
$1.22
$1.30
1-Wochen-Bereich:
Value
$1.22
$1.47
52-Wochen-Spanne:
Value
$1.22
$7.98

Cibus Inc Stock (CBUS) Company Profile

Name
Firmenname
Cibus Inc
Name
Telefon
(858) 450-0008
Name
Adresse
6455 NANCY RIDGE DRIVE, SAN DIEGO
Name
Mitarbeiter
159
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
CBUS's Discussions on Twitter

Vergleichen Sie CBUS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CBUS
Cibus Inc
1.2372 73.03M 1.82M -267.63M -50.53M -20.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.69 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
604.25 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
465.66 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
663.30 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.83 37.96B 3.81B -644.79M -669.77M -6.24

Cibus Inc Stock (CBUS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-29 Eingeleitet Alliance Global Partners Buy
2024-07-19 Fortgesetzt Canaccord Genuity Buy
2023-10-09 Eingeleitet H.C. Wainwright Buy
2023-07-19 Fortgesetzt Canaccord Genuity Buy

Cibus Inc Aktie (CBUS) Neueste Nachrichten

pulisher
Aug 20, 2025

Traders Consider Averaging Down in Cibus Inc.Weekly Market Summary & Consistent Profit Trading Strategies - thegnnews.com

Aug 20, 2025
pulisher
Aug 20, 2025

Will Cibus Inc. Benefit From Sector TailwindsJuly 2025 Setups & Daily Profit Maximizing Trade Tips - beatles.ru

Aug 20, 2025
pulisher
Aug 19, 2025

Backtesting results for Cibus Inc. trading strategiesDollar Strength & Fast Moving Stock Trade Plans - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Can Cibus Inc. hit a new high this monthWeekly Stock Summary & Verified Momentum Stock Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Will Cibus Inc. bounce back from current supportQuarterly Trade Summary & Daily Technical Stock Forecast Reports - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

When is the best time to exit Cibus Inc.July 2025 Summary & Low Drawdown Trading Strategies - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Is a relief rally coming for Cibus Inc. holdersEarnings Overview Summary & Fast Exit and Entry Trade Guides - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

How high can Cibus Inc. stock goPortfolio Performance Report & High Return Trade Opportunity Guides - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Cibus targets $200M annual royalty revenue from rice traits as regulatory landscape evolves - MSN

Aug 18, 2025
pulisher
Aug 18, 2025

Using data filters to optimize entry into Cibus Inc.July 2025 Analyst Calls & AI Based Buy and Sell Signals - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Cibus Reports Disappointing Q2 Earnings Amid Weak Market Reaction - AInvest

Aug 18, 2025
pulisher
Aug 17, 2025

Cibus, Inc. (NASDAQ:CBUS) Q2 2025 Earnings Call Transcript - MSN

Aug 17, 2025
pulisher
Aug 17, 2025

Signal strength of Cibus Inc. stock in tech scannersJuly 2025 Update & High Yield Stock Recommendations - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Price Channel Expanding on Cibus Inc.’s ChartJuly 2025 Sector Moves & Long-Term Safe Return Strategies - newsyoung.net

Aug 17, 2025
pulisher
Aug 17, 2025

Cibus Reports Q2 2025 Earnings: A Deep Loss Amid Weak Revenue and High Operating Costs - AInvest

Aug 17, 2025
pulisher
Aug 17, 2025

Combining machine learning predictions for Cibus Inc.2025 Volume Leaders & Daily Risk Controlled Trade Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Cibus Inc. Forms Double Bottom Pattern — Eyes on Breakout2025 Year in Review & Reliable Entry Point Alerts - 선데이타임즈

Aug 17, 2025
pulisher
Aug 16, 2025

Using AI based signals to follow Cibus Inc.Dividend Hike & Weekly Breakout Watchlists - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Smart tools for monitoring Cibus Inc.’s price actionEarnings Performance Report & Reliable Breakout Forecasts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Key resistance and support levels for Cibus Inc.Treasury Yields & Weekly Hot Stock Watchlists - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Leading vs lagging indicators on Cibus Inc. performanceJuly 2025 Snapshot & AI Forecasted Stock Moves - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Short Term Trend Reversal in Cibus Inc. PossibleWeekly Profit Analysis & Intraday High Probability Alerts - classian.co.kr

Aug 16, 2025
pulisher
Aug 16, 2025

Cibus Second Quarter 2025 Earnings: Misses Expectations - uk.finance.yahoo.com

Aug 16, 2025
pulisher
Aug 16, 2025

Should you wait for a breakout in Cibus Inc.2025 Short Interest & Consistent Profit Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

How moving averages guide Cibus Inc. tradingJuly 2025 Movers & Breakout Confirmation Trade Signals - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Tools to monitor Cibus Inc. recovery probability2025 Market Trends & Verified Trade Idea Suggestions - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

What data driven models say about Cibus Inc.’s futureWeekly Market Outlook & Momentum Based Trading Ideas - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Cibus, Inc. Reports Q2 2025 Financial Results - iGrow News

Aug 15, 2025
pulisher
Aug 15, 2025

Cibus Inc. shares fall 1.36% premarket after reporting second quarter financial results. - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Cibus Inc (CBUS) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial Outlook - Yahoo Finance

Aug 15, 2025
pulisher
Aug 15, 2025

Cibus (CBUS): Assessing the Path to Commercialization and Shareholder Value Realization - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Cibus' Q2 2025: Navigating Contradictions in EU Regulations and Biofragrance Revenue - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Cibus Q2 2025 Earnings Call Transcript - MarketBeat

Aug 15, 2025
pulisher
Aug 14, 2025

Cibus: Q2 Earnings Snapshot - Chron

Aug 14, 2025
pulisher
Aug 14, 2025

Transcript : Cibus, Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener

Aug 14, 2025
pulisher
Aug 14, 2025

Earnings call transcript: Cibus Q2 2025 sees stock rise 3.52% post-call - Investing.com Nigeria

Aug 14, 2025
pulisher
Aug 14, 2025

Earnings call transcript: Cibus Q2 2025 sees stock rise 3.52% post-call By Investing.com - Investing.com South Africa

Aug 14, 2025
pulisher
Aug 14, 2025

Cibus (CBUS) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Aug 14, 2025
pulisher
Aug 14, 2025

Cibus Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 14, 2025
pulisher
Aug 14, 2025

Regression Model Predicts Rangebound Movement in Cibus Inc.Recession Risk & Technical Buy Zone Confirmations - 선데이타임즈

Aug 14, 2025
pulisher
Aug 14, 2025

Cibus: Navigating Short-Term Losses to Unlock Long-Term Value in Agricultural Biotechnology - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Cibus, Inc. SEC 10-Q Report - TradingView

Aug 14, 2025
pulisher
Aug 14, 2025

Cibus Reports Second Quarter Financial Results and Provides Year-to-Date Business Update for 2025 - MarketScreener

Aug 14, 2025
pulisher
Aug 14, 2025

Gene Editing Pioneer Cibus Streamlines Operations, Secures Path to 2027 Rice Trait Launch - Stock Titan

Aug 14, 2025
pulisher
Aug 14, 2025

Cibus to Report Q2 2025 Financial Results and Host Conference Call on August 14, 2025 - AInvest

Aug 14, 2025

Finanzdaten der Cibus Inc-Aktie (CBUS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Cibus Inc-Aktie (CBUS) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Prante Gerhard
Director
Feb 24 '25
Sale
2.07
1,150
2,380
8,857
Prante Gerhard
Director
Feb 21 '25
Sale
2.20
1,150
2,530
10,007
Prante Gerhard
Director
Feb 20 '25
Sale
2.35
1,150
2,702
11,157
Prante Gerhard
Director
Feb 19 '25
Sale
2.58
1,150
2,967
12,307
Prante Gerhard
Director
Feb 18 '25
Sale
2.52
2,300
5,796
13,457
Prante Gerhard
Director
Feb 14 '25
Sale
2.60
1,150
2,990
15,757
Prante Gerhard
Director
Feb 13 '25
Sale
2.53
1,150
2,910
16,907
Prante Gerhard
Director
Feb 12 '25
Sale
2.45
1,150
2,818
18,057
Prante Gerhard
Director
Feb 11 '25
Sale
2.48
1,150
2,852
19,207
Prante Gerhard
Director
Feb 10 '25
Sale
2.52
1,150
2,898
20,357
$36.52
price down icon 0.88%
$86.71
price up icon 0.59%
$26.06
price up icon 0.83%
$110.00
price down icon 0.90%
$130.43
price up icon 0.73%
biotechnology ONC
$310.71
price up icon 0.64%
Kapitalisierung:     |  Volumen (24h):